Skip to nav Skip to content

IDSA Media Briefing: COVID Takeaways & Future Preparedness

Facebook Twitter LinkedIn Email

A COVID-19 briefing with experts from the Infectious Diseases Society of America:

Topical Agenda for March 25 Briefing:
- Preparing for future pandemics
- How COVID-19 vaccine development can inform future efforts
- Enduring health inequities
- Impending health threats, including antimicrobial resistance
- Questions from the media

Daniel P. McQuillen, MD, FIDSA, FACP—Burlington, MA (Moderator)
President Elect—Infectious Diseases Society of America
Director, Solid Organ Transplant Infectious Disease, Beth Israel Lahey Hospital & Medical Center
Assistant Professor of Medicine, Tufts University School of Medicine

Helen Boucher, MD, FIDSA, FACP—Boston, MA
Treasurer, Board of Directors—Infectious Diseases Society of America
Chief, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center
Director, Levy Center for Integrated Management of Antimicrobial Resistance (CIMAR), Tufts Medical Center

Angélica Cifuentes Kottkamp, MD, FIDSA—New York, NY
Member, Inclusion, Diversity, Access & Equity Task Force—Infectious Diseases Society of America
Assistant Professor of Medicine, NYU Grossman School of Medicine
Director, Bellevue Site, NYU Langone Vaccine Trial & Evaluation Unit

Matthew Zahn, MD, FIDSA—Santa Ana, CA
Fellow—Infectious Diseases Society of America
Medical Director, Division of Epidemiology and Assessment, Orange County Health Care Agency
Liaison Representative, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.